Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
08/24/2006 | WO2006088248A1 Polyoxyalkylene derivative |
08/24/2006 | WO2006088245A1 Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative |
08/24/2006 | WO2006088110A1 Novel protein promoting carbonic acid fixation and method of fixing carbonic acid by using the protein |
08/24/2006 | WO2006088010A1 Antimicrobial peptide and use thereof |
08/24/2006 | WO2006087550A2 Amyloid-binding peptides, analogues and uses thereof |
08/24/2006 | WO2006087533A2 Ricin-binding peptides and methods for use thereof |
08/24/2006 | WO2006087001A1 Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity |
08/24/2006 | WO2006043079A3 Compositions and methods for the control of mammary cell number |
08/24/2006 | WO2006041945A3 A counterion exchange process for peptides |
08/24/2006 | WO2006020981A3 Methods for accelerating bone growth and repair |
08/24/2006 | US20060189550 Immunostimulatory, Covalently lipidated oligonucleotides |
08/24/2006 | US20060189539 Novel GnRH analogues with antitumour effects and pharmaceutical compositions thereof |
08/24/2006 | US20060189538 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
08/24/2006 | US20060189517 Cross-linked glycopeptide-cephalosporin antibiotics |
08/24/2006 | US20060188935 Protein and its use in diagnosing Alzheimer's disease |
08/24/2006 | US20060188437 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
08/24/2006 | CA2598360A1 Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity |
08/24/2006 | CA2598316A1 Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative |
08/24/2006 | CA2598080A1 Amyloid-binding peptides, analogues and uses thereof |
08/23/2006 | EP1693673A2 Detection of auto-antibodies from patients suffering from rheumatoid arthritis |
08/23/2006 | EP1692265A2 Method of preventing virus: cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class i membrane fusogenic envelope proteins |
08/23/2006 | EP1692186A1 Cancer cell targeting gene delivery method |
08/23/2006 | EP1692160A2 Fgf-5 binding and supported peptides |
08/23/2006 | EP1692159A2 Tgf-beta binding and supported peptides |
08/23/2006 | EP1692158A2 Tgf-beta binding and supported peptides |
08/23/2006 | EP1692157A2 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
08/23/2006 | EP1691846A1 Peptides whose uptake by cells is controllable |
08/23/2006 | EP1507794B1 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
08/23/2006 | EP1240337B1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
08/23/2006 | EP1007566B1 Therapeutic use of the smr1 protein and active derivatives thereof |
08/23/2006 | EP0914827B1 Ophthalmic drug compositions |
08/23/2006 | CN1823087A Novel peptides that bind to the erythropoietin receptor |
08/23/2006 | CN1823086A Oligopeptide |
08/23/2006 | CN1821268A Goniothalamicim cyclopeptide B of anti-tumor compound and isomer and its preparing method |
08/22/2006 | US7094869 Animal growth regulators |
08/22/2006 | US7094868 Peptides for recognition and targeting of GLIAL cell tumors |
08/22/2006 | US7094761 A GPCR-like protein for treating glaucoma |
08/22/2006 | US7094760 Peptides for treatment of inflammation and shock |
08/22/2006 | US7094759 peptide having a specific amino acid sequence suppresses initial adhesion of intraoral bacteria to teeth and periodontal tissue and prevents formation of a biofilm in an oral cavity. |
08/22/2006 | US7094752 Peptide ligands of the urokinase receptor |
08/22/2006 | US7094579 Providing a culture of bacterial cells, adding rhanmose to the culture to induce rhamnose promoter whereby the antibody heavy chain and light chain and their linked signal sequences are expressed, secreted to the periplasm |
08/22/2006 | US7094552 Diagnostic test kits |
08/22/2006 | US7094549 mass spectroscopy; medical diagnosis/prognosis; kits |
08/22/2006 | US7094407 Self cell-penetrating Tat peptide having a self penetrating signal is bound to a human Type-I collagen C-terminal derived peptide |
08/22/2006 | US7094406 Enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes thereof |
08/17/2006 | WO2006086653A2 Methods and compositions for the treatment of gastrointestinal disorders |
08/17/2006 | WO2006085583A1 Cell permeable peptide |
08/17/2006 | WO2006031885A3 Kdr and vegf/kdr binding peptides |
08/17/2006 | WO2005056754A3 Compositions and methods to reduce mutagenesis |
08/17/2006 | WO2003087124A3 Hmgn2 peptides and related melecules that selectively home to tumor blood vessels and tumor cells |
08/17/2006 | US20060183884 Compounds and methods for modulating cell adhesion |
08/17/2006 | US20060183883 C5a Receptor antagonists |
08/17/2006 | US20060183689 Activation of peptide prodrugs by hK2 |
08/17/2006 | US20060183673 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof |
08/17/2006 | CA2597191A1 Antimicrobial hexapeptides |
08/17/2006 | CA2596505A1 Methods and compositions for the treatment of gastrointestinal disorders |
08/17/2006 | CA2580882A1 Antibiotic compound |
08/16/2006 | EP1690869A1 Peptide inhibiting angiontensin converting enzyme |
08/16/2006 | EP1689863A1 Template fixed beta-hairpin loop mimetics and their use in phage display |
08/16/2006 | EP1689852A2 Compositions and methods to reduce mutagenesis |
08/16/2006 | EP1689851A2 Modified polypeptides with therapeutic activity and methods of use |
08/16/2006 | EP1689778A1 Rgd targeting moiety its porduction and use |
08/16/2006 | EP1689773A2 Insulin releasing peptides |
08/16/2006 | EP1689771A1 Biologically active peptides comprising isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine (ivtntt) |
08/16/2006 | EP1689439A2 Small molecule compositions and methods for increasing drug efficiency using compositions thereof |
08/16/2006 | EP1689424A1 Use of cyclic anabaenopeptin-type peptides for the treatment of a condition wherein inhibition of carboxypeptidase u is beneficial, novel anabaenopeptin derivatives and intermediates thereof |
08/16/2006 | EP1165490B1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
08/16/2006 | EP1117682B1 Chi-Conotoxin Peptides as INhibitors of Neuronal Amine Transporters |
08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
08/16/2006 | CN1820019A Antimicrobial polypeptides |
08/16/2006 | CN1819837A TAMANDARIN analogs and fragments thereof and methods of making and using |
08/16/2006 | CN1817899A Polypeptide of ascidicea and preparation thereof |
08/16/2006 | CN1269958C Zinc finger binding domains for GNN |
08/16/2006 | CN1269837C Serial synthetic antibacterial peptide |
08/15/2006 | USRE39240 pure peptides which are highly selective for a specific human receptor; treatment of neuromuscular disorders, rapid reversible immobilization of muscles in vertebrate species; pesticide |
08/15/2006 | US7091314 Intermediates and methods for making heptapeptide oxytocin analogues |
08/15/2006 | US7091313 Coupling a solid support derived from polystyrene with N-protected derivative of amino acid, removing N-protecting group, coupling the product thus obtained with N-protected derivative of amino acid; removing protecting group, repeating the procedure, coupling, cyclization |
08/15/2006 | US7091311 Peptides and compounds that bind to a receptor |
08/15/2006 | US7091310 Chemokine analogs for the treatment of human disease |
08/15/2006 | US7091185 Periodic antimicrobial peptides |
08/15/2006 | US7091175 activating neovascularization by administering heptapeptides having replacements in the amino acid sequence; antiischemic agents; regeneration and maintenance of artificial bones |
08/15/2006 | US7091174 Caloxins |
08/15/2006 | US7090999 preparing pristinamycin IIA and/or IIB by introducing a disabling mutation into a gene that encodes 3-hydroxypicolinic acid:adenosine 5'-monopiosphate ligase; selecting and culturing cells containing the mutated gene that are blocked in the production of pristinamycin IA and IB |
08/15/2006 | US7090828 Vitronectin receptor antagonist pharmaceuticals |
08/10/2006 | WO2006084016A1 ACID ADDITION SALTS OF Ac-PHSCN-NH2 |
08/10/2006 | WO2006083927A2 Antimicrobial agent |
08/10/2006 | WO2006083317A2 Peptide antibiotics and methods for making same |
08/10/2006 | WO2006083016A1 Substrates for use in detection of phosphorylation-dephosphorylation reaction and detection method using the same |
08/10/2006 | WO2006027300A3 Carrier conjugates of gnrh-peptides |
08/10/2006 | WO2006005585A3 Secreted polypeptide species differentially expressed during pregnancy |
08/10/2006 | WO2005118621A3 Omi pdz modulators |
08/10/2006 | WO2003065999A3 Proliferated cell lines and uses thereof |
08/10/2006 | US20060178311 Control of lactation |
08/10/2006 | US20060178310 Intracellular delivery of biological effectors |
08/10/2006 | US20060177457 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest; for dual phototherapy of tumors and other lesions |
08/10/2006 | US20060177449 Antibody and use thereof |
08/10/2006 | CA2596357A1 Acid addition salts of ac-phscn-nh2 |
08/10/2006 | CA2571944A1 Peptide antibiotics and methods for making same |
08/09/2006 | EP1688486A1 Antibacterial peptide and utilization of the same |
08/09/2006 | EP1687637A1 High-throughput screening method for integrin antagonist and new peptide screened therefrom |